Lumbard & Kellner, LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 193 filers reported holding CARDLYTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
Lumbard & Kellner, LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q1 2022$359,000
-30.4%
6,547
-16.2%
0.14%
-28.2%
Q4 2021$516,000
-20.7%
7,813
+0.8%
0.20%
-23.5%
Q3 2021$651,000
-17.2%
7,752
+25.2%
0.26%
-16.1%
Q2 2021$786,000
+5.4%
6,190
-9.0%
0.30%
+16.0%
Q1 2021$746,000
-39.1%
6,799
-20.7%
0.26%
-45.6%
Q4 2020$1,224,0008,5740.48%
Other shareholders
CARDLYTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders